BamSEC and AlphaSense Join Forces
Learn More

Harrow Inc Com

NASDAQ: HROW    
Share price (1/3/25): $36.34    
Market cap (1/3/25): $1.294 billion
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from 10-K 15 pages Description of the Company’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 10-K 15 pages Description of the Company’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from 8-K 19 pages Harrow Health, Inc. and U.S. Bank Trust Company, National Association, as Trustee Second Supplemental Indenture Dated as of December 20, 2022 to the Indenture Dated as of April 20, 2021 11.875% Senior Notes Due 2027
12/34/56
EX-4.1
from 10-K 13 pages Description of the Company’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from 8-K 18 pages Harrow Health, Inc. and U.S. Bank National Association, as Trustee First Supplemental Indenture Dated as of April 20, 2021 to the Indenture Dated as of April 20, 2021 8.625% Senior Notes Due 2026
12/34/56
EX-4.1
from 8-K 59 pages Harrow Health, Inc. to U.S. Bank National Association as Trustee Indenture Dated as of April 20, 2021 Senior Debt Securities
12/34/56
EX-4.1
from 10-K 2 pages Description of the Company’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from S-3 65 pages Harrow Health, Inc. to as Trustee Indenture Dated as of , 20__ Subordinated Debt Securities
12/34/56
EX-4.1
from S-3 58 pages Harrow Health, Inc. to as Trustee Indenture Dated as of , 20 Senior Debt Securities
12/34/56
EX-4.1
from 10-K 2 pages Description of the Company’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from S-3 67 pages Imprimis Pharmaceuticals, Inc. to as Trustee Indenture Dated as of , 20__ Subordinated Debt Securities
12/34/56
EX-4.1
from S-3 59 pages Imprimis Pharmaceuticals, Inc. to as Trustee Indenture Dated as of , 20 Senior Debt Securities
12/34/56
EX-4.2
from S-3 67 pages Imprimis Pharmaceuticals, Inc. to as Trustee Indenture Dated as of , 20__ Subordinated Debt Securities
12/34/56
EX-4.1
from S-3 59 pages Imprimis Pharmaceuticals, Inc. to as Trustee Indenture Dated as of , 20 Senior Debt Securities
12/34/56